Hospira (HSP) Tops Q3 EPS by 21c; Sees FY EPS at Upper End of Prior Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Financial Fact:
Income From Operations: 218.6M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income From Operations: 218.6M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Hospira (NYSE: HSP) reported Q3 EPS of $0.74, $0.21 better than the analyst estimate of $0.53. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.08 billion.
Hospira sees FY2014 EPS of $2.40-$2.50, the upper-end of its prior range.
For earnings history and earnings-related data on Hospira (HSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- SelectQuote, Inc. (SLQT) Tops Q1 EPS by 13c ; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
